CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart

Karry Anne Belanger, Curtis A. Nutter, Jin Li, Sadia Tasnim, Peiru Liu, Peng Yu, Neslihan Martinez

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Dysregulated alternative splicing (AS) that contributes to diabetes pathogenesis has been identified, but little is known about the RNA binding proteins (RBPs) involved. We have previously found that the RBP CELF1 is upregulated in the diabetic heart; however, it is unclear if CELF1 contributes to diabetes-induced AS changes. Utilizing genome wide approaches, we identified extensive changes in AS patterns in Type 1 diabetic (T1D) mouse hearts. We discovered that many aberrantly spliced genes in T1D hearts have CELF1 binding sites. CELF1-regulated AS affects key genes within signaling pathways relevant to diabetes pathogenesis. Disruption of CELF1 binding sites impairs AS regulation by CELF1. In sum, our results indicate that CELF1 target RNAs are aberrantly spliced in the T1D heart leading to abnormal gene expression. These discoveries pave the way for targeting RBPs and their RNA networks as novel therapies for cardiac complications of diabetes.

Original languageEnglish (US)
Pages (from-to)3205-3211
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume503
Issue number4
DOIs
StatePublished - Sep 18 2018

Fingerprint

Alternative Splicing
Medical problems
RNA-Binding Proteins
Genes
Binding Sites
RNA
Recombinant DNA
Diabetes Complications
Gene expression
Genome
Gene Expression

Keywords

  • Alternative splicing
  • CELF1
  • Diabetic heart
  • RNA binding proteins

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart. / Belanger, Karry Anne; Nutter, Curtis A.; Li, Jin; Tasnim, Sadia; Liu, Peiru; Yu, Peng; Martinez, Neslihan.

In: Biochemical and Biophysical Research Communications, Vol. 503, No. 4, 18.09.2018, p. 3205-3211.

Research output: Contribution to journalArticle

Belanger, Karry Anne ; Nutter, Curtis A. ; Li, Jin ; Tasnim, Sadia ; Liu, Peiru ; Yu, Peng ; Martinez, Neslihan. / CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart. In: Biochemical and Biophysical Research Communications. 2018 ; Vol. 503, No. 4. pp. 3205-3211.
@article{d2147111c7ad4841aac13e5006c2f8d6,
title = "CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart",
abstract = "Dysregulated alternative splicing (AS) that contributes to diabetes pathogenesis has been identified, but little is known about the RNA binding proteins (RBPs) involved. We have previously found that the RBP CELF1 is upregulated in the diabetic heart; however, it is unclear if CELF1 contributes to diabetes-induced AS changes. Utilizing genome wide approaches, we identified extensive changes in AS patterns in Type 1 diabetic (T1D) mouse hearts. We discovered that many aberrantly spliced genes in T1D hearts have CELF1 binding sites. CELF1-regulated AS affects key genes within signaling pathways relevant to diabetes pathogenesis. Disruption of CELF1 binding sites impairs AS regulation by CELF1. In sum, our results indicate that CELF1 target RNAs are aberrantly spliced in the T1D heart leading to abnormal gene expression. These discoveries pave the way for targeting RBPs and their RNA networks as novel therapies for cardiac complications of diabetes.",
keywords = "Alternative splicing, CELF1, Diabetic heart, RNA binding proteins",
author = "Belanger, {Karry Anne} and Nutter, {Curtis A.} and Jin Li and Sadia Tasnim and Peiru Liu and Peng Yu and Neslihan Martinez",
year = "2018",
month = "9",
day = "18",
doi = "10.1016/j.bbrc.2018.08.126",
language = "English (US)",
volume = "503",
pages = "3205--3211",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart

AU - Belanger, Karry Anne

AU - Nutter, Curtis A.

AU - Li, Jin

AU - Tasnim, Sadia

AU - Liu, Peiru

AU - Yu, Peng

AU - Martinez, Neslihan

PY - 2018/9/18

Y1 - 2018/9/18

N2 - Dysregulated alternative splicing (AS) that contributes to diabetes pathogenesis has been identified, but little is known about the RNA binding proteins (RBPs) involved. We have previously found that the RBP CELF1 is upregulated in the diabetic heart; however, it is unclear if CELF1 contributes to diabetes-induced AS changes. Utilizing genome wide approaches, we identified extensive changes in AS patterns in Type 1 diabetic (T1D) mouse hearts. We discovered that many aberrantly spliced genes in T1D hearts have CELF1 binding sites. CELF1-regulated AS affects key genes within signaling pathways relevant to diabetes pathogenesis. Disruption of CELF1 binding sites impairs AS regulation by CELF1. In sum, our results indicate that CELF1 target RNAs are aberrantly spliced in the T1D heart leading to abnormal gene expression. These discoveries pave the way for targeting RBPs and their RNA networks as novel therapies for cardiac complications of diabetes.

AB - Dysregulated alternative splicing (AS) that contributes to diabetes pathogenesis has been identified, but little is known about the RNA binding proteins (RBPs) involved. We have previously found that the RBP CELF1 is upregulated in the diabetic heart; however, it is unclear if CELF1 contributes to diabetes-induced AS changes. Utilizing genome wide approaches, we identified extensive changes in AS patterns in Type 1 diabetic (T1D) mouse hearts. We discovered that many aberrantly spliced genes in T1D hearts have CELF1 binding sites. CELF1-regulated AS affects key genes within signaling pathways relevant to diabetes pathogenesis. Disruption of CELF1 binding sites impairs AS regulation by CELF1. In sum, our results indicate that CELF1 target RNAs are aberrantly spliced in the T1D heart leading to abnormal gene expression. These discoveries pave the way for targeting RBPs and their RNA networks as novel therapies for cardiac complications of diabetes.

KW - Alternative splicing

KW - CELF1

KW - Diabetic heart

KW - RNA binding proteins

UR - http://www.scopus.com/inward/record.url?scp=85052863867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052863867&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2018.08.126

DO - 10.1016/j.bbrc.2018.08.126

M3 - Article

C2 - 30158053

AN - SCOPUS:85052863867

VL - 503

SP - 3205

EP - 3211

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -